Clinical Trial Detail

NCT ID NCT03132454
Title Study of Palbociclib Alone and in Combination in Patients With Relapsed and Refractory (R/R) Leukemias
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

Decitabine + Palbociclib

Dexamethasone + Palbociclib

Palbociclib

Palbociclib + Sorafenib

Age Groups: adult child senior

No variant requirements are available.